☆ 4.7 Article

Gemcitabine-loaded synthetic high-density lipoprotein preferentially eradicates hepatic monocyte-derived macrophages in mouse liver with colorectal cancer metastases

ACTA PHARMACOLOGICA SINICA (2023)

Related references

Note: Only part of the references are listed.

Review Chemistry, Multidisciplinary

Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights

Jiao-jiao Ni et al.

Summary: As a breakthrough strategy for cancer treatment, immunotherapy stimulates the immune system to fight cancer, providing a durable antitumor response. Due to the low response rate and unique toxicity profiles of immunotherapy, combining it with other therapies has gained attention. Immune-based combination therapy has achieved promising results in clinical trials, with FDA approval for certain cancers.

ACTA PHARMACOLOGICA SINICA (2023)

Add to Collection

Review Biochemistry & Molecular Biology

High-density lipoproteins: A promising tool against cancer

Alice Ossoli et al.

Summary: High-density lipoproteins (HDL) play a protective role against atherosclerosis and may also impact cancer cell proliferation and tumor progression. Through mechanisms such as reducing cancer cell cholesterol content and decreasing oxidative stress and inflammation, HDL can help inhibit cancer development.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2022)

Add to Collection

Review Chemistry, Multidisciplinary

Nanomaterials targeting tumor associated macrophages for cancer immunotherapy

Caiyan Zhao et al.

Summary: TAMs are key players in tumor progression and can be modulated using nanotechnology-based strategies, such as inhibiting their recruitment, depleting M2-polarized macrophages, and reprogramming them into M1-polarized macrophages. Nanoparticles can also be used to image TAMs for novel treatment options and therapy monitoring.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Nanomaterials with changeable physicochemical property for boosting cancer immunotherapy

Qiankun Ni et al.

Summary: This article reviews the application of nanomaterials with changeable physicochemical properties in cancer immunotherapy. Despite significant progress in cancer immunotherapy, there are still hurdles to overcome, and the properties of nanomaterials hold potential to address these challenges.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Modified citrus pectin inhibits breast cancer development in mice by targeting tumor-associated macrophage survival and polarization in hypoxic microenvironment

Lei Wang et al.

Summary: The study showed that modified citrus pectin (MCP) can inhibit the survival and polarization of tumor-associated macrophages (TAM) in tumor tissue, leading to suppression of breast cancer growth and migration. MCP reduces TAM function by inhibiting glucose uptake, reducing ROS levels, and suppressing M2-like polarization. Furthermore, MCP treatment significantly decreases the number of TAM in both tumor and lung tissue, suggesting its potential as a promising agent for targeting TAM in breast cancer treatment.

ACTA PHARMACOLOGICA SINICA (2022)

Add to Collection

Article Chemistry, Multidisciplinary

ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH/PSAT1/serine metabolic pathway

Sha Li et al.

Summary: Colorectal cancer (CRC) is a common cancer globally, especially among women. In this study, alcohol dehydrogenase 1C (ADH1C) was identified as a potential drug target for CRC. Overexpression of ADH1C inhibited the growth and invasion of CRC cells, indicating its therapeutic potential for CRC.

ACTA PHARMACOLOGICA SINICA (2022)

Add to Collection

Article Pharmacology & Pharmacy

High density lipoprotein nanoparticle as delivery system for radio-sensitising miRNA: An investigation in 2D/3D head and neck cancer models

Pouya Dehghankelishadi et al.

Summary: This study demonstrates the potential of using high-density lipoprotein nanoparticles as a delivery system for radio-sensitising RNA in head and neck cancer cells. The results show enhanced radiation effects and increased apoptosis when miR34a is delivered by HDL nanoparticles.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer

Chao Zheng et al.

Summary: This study designed a synthetic high-density lipoprotein (LV-sHDL) loaded with lenvatinib and vadimezan for the combination immunochemotherapy of metastatic triple-negative breast cancer (TNBC). The use of LV-sHDL improved the intratumoral infiltration of cytotoxic T lymphocytes (CTLs), inhibited tumor growth and metastasis, and prolonged survival.

ACTA PHARMACEUTICA SINICA B (2022)

Add to Collection

Review Immunology

The complex role of tumor-infiltrating macrophages

Anthos Christofides et al.

Summary: This article reviews the characteristics of tumor-associated macrophages (TAMs) and discusses the mechanisms that contribute to their pathological adaptations to the tumor microenvironment. TAMs play a crucial role in the tumor microenvironment and are closely associated with cancer progression.

NATURE IMMUNOLOGY (2022)

Add to Collection

Review Biotechnology & Applied Microbiology

Macrophages as tools and targets in cancer therapy

Alberto Mantovani et al.

Summary: This review discusses the molecular mechanisms of macrophage reprogramming in the tumor microenvironment and provides an overview of macrophage-targeted therapies for cancer treatment.

NATURE REVIEWS DRUG DISCOVERY (2022)

Add to Collection

Review Chemistry, Multidisciplinary

Nanosized drug delivery systems modulate the immunosuppressive microenvironment to improve cancer immunotherapy

Wen-lu Yan et al.

Summary: Despite the clinical benefits of immune activation in cancer treatment, the immunosuppressive tumor microenvironment (ITME) poses a major challenge. This review explores strategies using nanosized drug delivery systems (NDDSs) to modulate ITME, including triggering immunogenetic cell death, utilizing tumor vaccines, and directly regulating intratumoral immune components. The contributions and future directions in this field are also discussed.

ACTA PHARMACOLOGICA SINICA (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade

Zhiren Wang et al.

Summary: Camptothesome is an innovative nanovesicle therapeutic that has shown promising results in the treatment of colorectal cancer. It is taken up by cancer cells through a specific pathway and induces immunogenic cancer cell death. The use of Camptothesome-treated tumor cells as a vaccine has proven effective in preventing tumor growth. Furthermore, Camptothesome demonstrates superior anti-cancer efficacy and immune response compared to other treatments. It also enhances the effectiveness of immune checkpoint inhibitors in shrinking late-stage CRC tumors and prolonging survival.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Colorectal liver metastasis: molecular mechanism and interventional therapy

Hui Zhou et al.

Summary: This review summarizes the mechanisms, diagnosis, and treatment of colorectal liver metastasis (CRLM), with a special focus on the tumor microenvironment and the potential of newer targeted therapies to improve patient prognosis.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Sphingomyelin synthase 2 facilitates M2-like macrophage polarization and tumor progression in a mouse model of triple-negative breast cancer

Yan Deng et al.

Summary: High infiltration of M2-polarized macrophages in primary TNBC tumors is associated with poor prognosis. This study demonstrates that targeting SMS2 may be a novel therapeutic strategy for TNBC by inhibiting M2 macrophages polarization and tumor progression. Knockout of SMS2 or treatment with a specific SMS2 inhibitor resulted in reduced M2-type macrophages, tumor weight, and metastasis in a mouse model of TNBC, leading to an improved infiltration of antitumor immune cells.

ACTA PHARMACOLOGICA SINICA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination

Jiali Yu et al.

Summary: Liver metastases diminish the efficacy of immunotherapy by siphoning activated CD8(+) T cells from systemic circulation, creating systemic immune desert. Combining liver-directed radiotherapy with immunotherapy can promote systemic antitumor immunity.

NATURE MEDICINE (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Pharmacology & Pharmacy

Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy

Yuanyuan He et al.

Summary: The tumor microenvironment is crucial in regulating antitumor immune responses, with a focus on M2 macrophages. Immunotherapy approaches targeting tumor-associated macrophages aim to reduce the immunosuppressive state, however, facing limitations such as drug degradation rate and cytotoxicity. Nanomedicine formulations offer promising strategies in cancer therapy by specifically targeting M2 TAMs, reducing side effects and enhancing therapeutic potential.

PHARMACEUTICS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

High-density lipoprotein modulates tumor-associated macrophage for chemoimmunotherapy of hepatocellular carcinoma

Junyang Wang et al.

Summary: This study suggests that synthetic high-density lipoproteins (sHDLs) can deliver drugs selectively to tumor cells, improving prognosis in patients with hepatocellular carcinoma. The findings show that VG-sHDLs induce the release of various molecules and cytokines from HCC cells, promoting differentiation into activated macrophages and enhancing immune cell activity, leading to improved tumor eradication.

NANO TODAY (2021)

Add to Collection

Review Medicine, General & Internal

Liver metastases

Diamantis I. Tsilimigras et al.

Summary: Liver metastases are commonly detected in various malignancies, with interactions between tumor cells and the microenvironment playing a crucial role. Treatment options include surgical resection, systemic therapies, and newer biologic agents, with the incorporation of genetic tests providing more accurate information for clinical decision-making.

NATURE REVIEWS DISEASE PRIMERS (2021)

Add to Collection

Article Oncology

Apolipoprotein mimetics in cancer

Samuel C. Delk et al.

Summary: Peptides have advantages over traditional therapeutics due to low toxicity and immunogenicity and have shown efficacy in treating various cancers. Apolipoprotein mimetic peptides, such as oral apoA-I mimetic peptides, can remodel HDL and improve cancer progression.

SEMINARS IN CANCER BIOLOGY (2021)

Add to Collection

Review Oncology

The immunological and metabolic landscape in primary and metastatic liver cancer

Xin Li et al.

Summary: This review discusses the unique immunological and metabolic features of the liver during cancer development, and how these factors can impact the development of primary liver cancer and liver metastases. The liver is often influenced by chronic inflammation and metabolic alterations, which may affect cancer metastasis.

NATURE REVIEWS CANCER (2021)

Add to Collection

Review Materials Science, Biomaterials

Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy

Yijun Mei et al.

Summary: rHDL is a synthesized drug delivery nanoplatform with excellent biocompatibility and active-targeting ability, which improves the therapeutic effect of antitumor drugs.

JOURNAL OF MATERIALS CHEMISTRY B (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery

Yuqiong Xia et al.

ADVANCED MATERIALS (2020)

Add to Collection

Review Immunology

Immune surveillance of the liver by T cells

Xenia Ficht et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer

T. Andre et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Oncology

Colon-specific immune microenvironment regulates cancer progression versus rejection

Giulia Trimaglio et al.

ONCOIMMUNOLOGY (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy

Anujan Ramesh et al.

NANOSCALE (2020)

Add to Collection

Review Oncology

Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy

Davide Ciardiello et al.

CANCER TREATMENT REVIEWS (2019)

Add to Collection

Article Oncology

Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy

Eric Deutsch et al.

LANCET ONCOLOGY (2019)

Add to Collection

Review Immunology

Liver-Mediated Adaptive Immune Tolerance

Meijuan Zheng et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer

Jackie E. Bader et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)

Add to Collection

Review Oncology

Targeting CD47 as a cancer therapeutic strategy: the cutaneous T-cell lymphoma experience

Alecia S. Folkes et al.

CURRENT OPINION IN ONCOLOGY (2018)

Add to Collection

Article Engineering, Biomedical

Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency

Yue Han et al.

BIOMATERIALS (2018)

Add to Collection

Review Gastroenterology & Hepatology

Targeting hepatic macrophages to treat liver diseases

Frank Tacke

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages

Yuan Qian et al.

ACS NANO (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells

Joao Conde et al.

ADVANCED FUNCTIONAL MATERIALS (2015)

Add to Collection

Editorial Material Urology & Nephrology

Re: Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer

Timothy J. Daskivich et al.

EUROPEAN UROLOGY (2015)

Add to Collection

Article Oncology

Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma

Christina Hackl et al.

BMC CANCER (2014)

Add to Collection

Article Gastroenterology & Hepatology

Activated tumor-infiltrating CD4+regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer

Alexander Pedroza-Gonzalez et al.

HEPATOLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

Recruitment of a Myeloid Cell Subset (CD11b/Gr1mid) via CCL2/CCR2 Promotes the Development of Colorectal Cancer Liver Metastasis

Lei Zhao et al.

HEPATOLOGY (2013)

Add to Collection

Article Chemistry, Multidisciplinary

Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery

Golam Kibria et al.

JOURNAL OF CONTROLLED RELEASE (2011)

Add to Collection

Article Surgery

Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution

Michael G. House et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2010)

Add to Collection

Article Oncology

Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?

Rene Adam et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Add to Collection

Review Oncology

Meta-analysis of hepatic arterial infusion for unresectable liver Metastases from colorectal cancer: The end of an era?

Simone Mocellin et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Add to Collection

Article Oncology

Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer

H Sorbye et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

Add to Collection

Article Oncology

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

A de Gramont et al.

JOURNAL OF CLINICAL ONCOLOGY (2000)

Add to Collection

Article Medicine, General & Internal

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

JY Douillard et al.

LANCET (2000)

Add to Collection

Review Immunology

The liver as a site of T-cell apoptosis: graveyard, or krilling field?

IN Crispe et al.

IMMUNOLOGICAL REVIEWS (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.